当前位置: X-MOL 学术Br. J. Ophthalmol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Choroidal thickness in patients with thyroid-associated ophthalmopathy, as determined by swept-source optical coherence tomography
British Journal of Ophthalmology ( IF 3.7 ) Pub Date : 2024-08-01 , DOI: 10.1136/bjo-2023-323694
Sisi Zhong 1, 2 , Fanglin He 1, 2 , Sijie Fang 1, 2, 3, 4 , Jing Sun 1, 2 , Yinwei Li 1, 2 , Zhang Shuo 1, 2 , Xingtong Liu 1, 2 , Xuefei Song 1, 2 , Yang Wang 1, 2 , Yazhuo Huang 1, 2, 3, 4 , Huifang Zhou 2, 5 , Xianqun Fan 2, 5
Affiliation  

Aim This study used swept-source optical coherence tomography (SS-OCT) to investigate subfoveal choroidal thickness (SFCT) in patients with thyroid-associated ophthalmopathy (TAO) who displayed different levels of disease activity and severity. Methods Thirty patients with TAO (60 eyes) and 38 healthy controls (67 eyes) in Shanghai, China, were recruited for this study. Disease activity and severity were graded using European Group on Graves’ Orbitopathy standardised criteria. SFCT values were determined by SS-OCT. Results In total, 129 eyes were included in the final analysis. The mean SFCT was significantly thicker among patients with active disease (276.23±84.01 µm) than among patients with inactive disease (224.68±111.61 µm; p=0.049) or healthy controls (223.56±78.69 µm; p=0.01). There were no differences in SFCT among patients with moderate-to-severe disease, patients with severe disease and healthy controls (p>0.05). Changes in SFCT demonstrated strong predictive ability to distinguish active TAO from inactive TAO (area under the curve=0.659, 95% CI 0.496 to 0.822). Conclusions SFCT was strongly associated with Clinical Activity Score in patients with TAO. Choroidal thickening was observed during active TAO. SS-OCT offers a non-invasive method for follow-up assessment. Data are available on reasonable request.
更新日期:2024-07-23
down
wechat
bug